跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DD-2
首页
药物
DD-2
DD-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Process for providing submodel performance in a computer processing unit
申请人: BULL HN INFORMATION SYST
优先权: 2004
US
3 件公开
HETEROCYCLIC COMPOUND
申请人: FIMECS INC
优先权: 2019
CN
WO
2 件公开
Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
申请人: ALLEN DAVID G
优先权: 2002
US
2 件公开
Vaccines against infections caused by YF virus; YF infectious cDNA, method for producing a recombinant YF virus from the YF infectious cDNA and plasmids to assemble the YF infectious cDNA
申请人: FUNDACAO OSWALDO CRUZ
优先权: 2000
US
Process for the preparation of D-ribavirin
申请人: ARCHIMICA SRL
优先权: 2001
US
Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
申请人: GLAXO GROUP LTD
优先权: 2003
CN
Mono-nitration of aromatic compounds
申请人: HOFFMANN LA ROCHE
优先权: 2006
CN
ANTI-TUMOR ACTIVITY OF AECHL-1, NOVEL TRITERPENOID ISOLATED FROM AILANTHUS EXCELSA IN VITRO AND IN VIVO
申请人: NAT CT FOR CELL SCIENCE
优先权: 2008
US
Natural tocopherol extract method
申请人: SHAANXI QINLING BIOTECHNOLOGY CO LTD
优先权: 2014
CN
Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
申请人: UNIV BASEL
优先权: 2015
CN
第 1 / 2 页
上一页
下一页
药物
反馈